Clinical Trial Update: Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of SR121463B in Syndrome of inappropriate antidiuretic hormone secretion and hyponatremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• SR121463B

Snippet

Sponsor: Sanofi | Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion, Hyponatremia | Phase 2 | Status: COMPLETED